Tau PET/CT scan study for people with related diseases
Part of Brain & nervous system, Mental health clinical trials.
This study uses a special scan (Tau PET/CT) to look at tau protein in the brain or body. It may help doctors understand tau-related diseases better, and is open to adults who are scheduled for this scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a suspected, newly diagnosed, or previously treated malignant tumor (cancer) based on medical records like MRI, CT, or biopsy
- You are already scheduled to have a Tau PET/CT scan as part of your care
- You or your legal guardian can sign a consent form agreeing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special imaging agent called [18F]NIDF to take pictures of tau protein clumps in the brain, which are linked to Alzheimer's and other memory or movement disorders. It may help doctors see these changes more clearly.
This study tests a special PET scan that looks at a protein called TSPO, which may be active in tumors. It may help doctors understand and monitor certain cancers better.
This trial is testing whether a special scan (beta-amyloid PET/CT) can help detect abnormal protein clumps in the brain that are linked to certain diseases, including cancer. The scan might help doctors better understand and track these conditions.
This study uses a special PET scan to see how a new tracer (18F-JSS20-183A) moves through the body and brain. It may help researchers learn more about brain diseases like Parkinson's and Alzheimer's.
This study uses brain imaging and tests to better understand Parkinson's disease and related conditions. It aims to improve diagnosis by comparing scans across different groups of people.
This study uses a special PET/CT scan to look at amino acid transporters in tumors. It may help doctors better understand and diagnose certain cancers.
Hear when a new Tauopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.